autologous dendritic cell vaccine ACT2001
Term · Oncology and biomedicine · MLC-T-ONC-011599
A cell-based cancer vaccine composed of autologous, immature dendritic cells (DCs), with potential immunostimulating and antineoplastic activities. Upon leukapheresis, immature DCs are isolated and re-administered intra-tumorally. The immature DCs internalize and process the tumor-associated antigens (TAAs), migrate to the lymphatic system, and then expose the immune system to the TAAs. This induces a specific cytotoxic T-lymphocyte (CTL) response against the cancer cells leading to tumor cell lysis.
| Identifier | MLC-T-ONC-011599 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | autologous DC vaccine ACT2001 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011599",
"term": "autologous dendritic cell vaccine ACT2001",
"field": "Oncology and biomedicine",
"definition": "A cell-based cancer vaccine composed of autologous, immature dendritic cells (DCs), with potential immunostimulating and antineoplastic activities. Upon leukapheresis, immature DCs are isolated and re-administered intra-tumorally. The immature DCs internalize and process the tumor-associated antigens (TAAs), migrate to the lymphatic system, and then expose the immune system to the TAAs. This induces a specific cytotoxic T-lymphocyte (CTL) response against the cancer cells leading to tumor cell lysis.",
"synonyms": [
"autologous DC vaccine ACT2001"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-dendritic-cell-vaccine-act2001/"
}
Record 2,933 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.